INFLUENCE OF DIET ON EXPERIMENTAL TOXICITY OF AMPHOTERICIN-B DEOXYCHOLATE

被引:31
作者
CHAVANET, P
JOLY, V
RIGAUD, D
BOLARD, J
CARBON, C
YENI, P
机构
[1] FAC XAVIER BICHAT,INSERM,U13,F-75018 PARIS,FRANCE
[2] FAC XAVIER BICHAT,U286,PARIS,FRANCE
[3] LAB PHYS & CHIM BIOMOLEC,CNRS,U198,PARIS,FRANCE
关键词
D O I
10.1128/AAC.38.5.963
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The effects of pre- and postprandial levels of lipids in serum on the experimental in vivo and in vitro toxicities of amphotericin B deoxycholate (AmB-d) were studied. Normal OF1 mice were tested at baseline, after normal feeding, after 3 h of fasting, or after a sequence of feeding and fasting and vice versa. The 50% lethal dose (LD(50)) of AmB-d was significantly higher in fed mice than in mice which fasted or at baseline (2.38 +/- 0.12 versus 1.53 +/- 0.2 and 1.50 +/- 0.1 mg/kg of body weight, respectively; P < 0.05). When different nutritional regimens were alternated over a short period, the level of in vivo AmB-d toxicity was dictated by the last feeding regimen. Serum triglycerides, but not cholesterol in very-low-density and low-density lipoproteins, correlated significantly (P < 0.01) with the LD(50) of AmB. In vitro experiments showed that the addition of human serum reduced AmB-d-induced toxicity against human erythrocytes, but serum drawn,vn after fasting was less protective than postprandial serum. However, neither serum decreased the in vitro activity of AmB-d against Candida albicans. Circular dichroism, a method that enables the amount of free AmB to be measured, showed that both mouse and human total serum lipoproteins bound more AmB-d when serum was isolated postprandially than when it was obtained after fasting. Our results show that AmB-d toxicity is reduced by feeding-induced modifications in serum lipids. The influeuce of food intake on the clinical toxicity of the drug merits being investigated.
引用
收藏
页码:963 / 968
页数:6
相关论文
共 27 条
[1]   AMPHOTERICIN-B PHARMACOKINETICS IN HUMANS [J].
ATKINSON, AJ ;
BENNETT, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (02) :271-276
[2]  
BARCWICZ J, 1992, ANTIMICROB AGENTS CH, V36, P2310
[3]   INHIBITION OF THE INTERACTION BETWEEN LIPOPROTEINS AND AMPHOTERICIN-B BY SOME DELIVERY SYSTEMS [J].
BARWICZ, J ;
GAREAU, R ;
AUDET, A ;
MORISSET, A ;
VILLIARD, J ;
GRUDA, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (02) :722-728
[4]   ONE-SIDED ACTION OF AMPHOTERICIN-B ON CHOLESTEROL-CONTAINING MEMBRANES IS DETERMINED BY ITS SELF-ASSOCIATION IN THE MEDIUM [J].
BOLARD, J ;
LEGRAND, P ;
HEITZ, F ;
CYBULSKA, B .
BIOCHEMISTRY, 1991, 30 (23) :5707-5715
[5]   INTERACTION OF PLASMA-PROTEINS AND LIPOPROTEINS WITH AMPHOTERICIN-B [J].
BRAJTBURG, J ;
ELBERG, S ;
BOLARD, J ;
KOBAYASHI, GS ;
LEVY, RA ;
OSTLUND, RE ;
SCHLESSINGER, D ;
MEDOFF, G .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (06) :986-997
[6]   EFFECTS OF SERUM-LIPOPROTEINS ON DAMAGE TO ERYTHROCYTES AND CANDIDA-ALBICANS CELLS BY POLYENE ANTIBIOTICS [J].
BRAJTBURG, J ;
ELBERG, S ;
KOBAYASHI, GS ;
MEDOFF, G .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (03) :623-626
[7]   AMPHOTERICIN-B - DELIVERY SYSTEMS [J].
BRAJTBURG, J ;
POWDERLY, WG ;
KOBAYASHI, GS ;
MEDOFF, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (03) :381-384
[8]  
Burnstein M, 1970, J LIPID RES, V11, P583
[9]   SERUM LIPOPROTEIN AND APOLIPOPROTEIN PROFILES OF THE GENETICALLY-OBESE OB OB MOUSE [J].
CAMUS, MC ;
AUBERT, R ;
BOURGEOIS, F ;
HERZOG, J ;
ALEXIU, A ;
LEMONNIER, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 961 (01) :53-64
[10]  
CAMUS MC, 1983, J LIPID RES, V24, P1210